mercredi 22 août 2018

Onco Actu du 22 août 2018

3.1.1 Prévention - Tabac - e-cigs

Israel bans Juul e-cigarettes citing 'grave' public health risk [Reuters]

4.10 Dép., diag. & prono. - FDA, EMA, NICE,...

Agilent Companion Diagnostic Gains Expanded FDA Approval in Urothelial Carcinoma [Agilent]

FDA Approves Expanded Use of Agilent Assay as Keytruda CDx for Urothelial Cancer [Genome Web]

4.12 Biopsies liquides

Tumor cells’ ‘tells’ may allow some cancer patients to dodge unnecessary chemotherapy [Stanford Medicine]

4.7 Dép., diag. & prono. - Col de l'utérus

For Cervical Cancer Screening, Women Over 30 Can Now Choose The HPV Test Only [NPR]

Cervical Cancer: Screening [USPSTF]

Cervical cancer screening without Pap test OK for some women [Reuters]

5.1 Traitements - Pré-clinique

Scientists discover first step towards finding a new, targeted lung cancer treatment [Cancer Research UK]

5.10 Traitements - Essais

Treatment extends lives of patients with terminal ovarian and lung cancers [The Guardian]

Drug combination gives ‘exciting’ results in ovarian and lung cancer in early trial [Institute of Cancer Research]

5.12.2 Immunothérapies - CAR-T, thérapies cellulaires

First in-depth profile of CAR T-cell signals suggests how to improve immunotherapy [Fred Hutch]

Overlooked molecule might be key to how well cancer-fighting CAR-T cells work [STAT]

5.12.6 Immunothérapies - AMM

With FDA's new 'real-time' review, Merck's Keytruda scores paramount nod in lung cancer [FiercePharma]

FDA gives Merck ‘real-time’ OK for Keytruda, offering a peek at the latest extension of the agency’s data express highway [EndPoints]

5.2 Pharma

Pfizer’s lorlatinib clears first hurdle to UK early access scheme [Pharma Times]

5.2.1 Pharma - Partenariats

Development partner Boehringer Ingelheim supplies clinical material manufactured in China for new cancer drug [Boehringer Ingelheim]

5.3.4 Traitements - AMM (FDA, EMA,...)

EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim [ESMO]

6. Lutte contre les cancers

Is Everything Healthy in Cancer Research? [Damon Runyon Blog]

6.10.1 Politiques (USA)

In defiance of Trump’s budget, Senate poised to boost NIH funding—again [FierceBiotech]